QuickView for cytoplasmic sequestering of NF-kappaB (biogroup)

1. Differences in the response to LPS and OxPAPC of macrophages from HMDP mouse strains
2. L1000 CMAP - Skeletal muscle SKL.C cells treated with small molecule perturbagens
3. L1000 CMAP - Umbilical vein endothelial HUVEC cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
5. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens

There were no matches for cytoplasmic sequestering of NF-kappaB

There were no clinical trials for cytoplasmic sequestering of NF-kappaB